NPI: 1013924372 · NEW YORK, NY 10029 · Internal Medicine Physician · NPI assigned 08/01/2006
Authorized official KARLIN, MARJI controls 19+ related entities in our dataset. Read more
| Authorized Official | KARLIN, MARJI (CHIEF REVENUE OFFICER) |
| NPI Enumeration Date | 08/01/2006 |
Other providers sharing the same authorized official: KARLIN, MARJI
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 79,873 | $280K |
| 2019 | 135,382 | $5.29M |
| 2020 | 321,330 | $15.59M |
| 2021 | 578,006 | $26.05M |
| 2022 | 500,557 | $23.56M |
| 2023 | 344,641 | $15.69M |
| 2024 | 317,182 | $14.32M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 121,596 | 107,300 | $10.49M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 46,506 | 42,127 | $8.55M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 77,344 | 68,254 | $6.56M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 32,739 | 29,652 | $6.17M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 67,592 | 58,316 | $4.48M |
| G0378 | Hospital observation service, per hour | 3,062 | 2,969 | $3.38M |
| S9123 | Nursing care, in the home; by registered nurse, per hour (use for general nursing care only, not to be used when cpt codes 99500-99602 can be used) | 9,185 | 8,921 | $3.04M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 11,654 | 10,826 | $2.46M |
| 90832 | Psychotherapy, 30 minutes with patient | 19,074 | 10,997 | $2.35M |
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 51,105 | 7,649 | $2.13M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 28,064 | 25,076 | $1.92M |
| 36415 | Collection of venous blood by venipuncture | 150,167 | 86,472 | $1.88M |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 15,725 | 15,263 | $1.85M |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 12,088 | 11,800 | $1.84M |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 21,015 | 534 | $1.28M |
| 99215 | Prolong outpt/office vis | 7,683 | 7,454 | $1.20M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5,460 | 5,240 | $1.19M |
| J1644 | Injection, heparin sodium, per 1000 units | 22,589 | 2,029 | $1.15M |
| 90834 | Psychotherapy, 45 minutes with patient | 7,414 | 5,099 | $1.12M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 64,098 | 55,388 | $1.09M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 26,133 | 15,165 | $1.09M |
| 90792 | Psychiatric diagnostic evaluation with medical services | 4,111 | 3,734 | $994K |
| 99205 | Prolong outpt/office vis | 4,642 | 4,580 | $837K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 15,912 | 15,048 | $832K |
| 81408 | 532 | 529 | $742K | |
| 70450 | Computed tomography, head or brain; without contrast material | 3,631 | 3,524 | $722K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1,138 | 1,106 | $697K |
| S9131 | Physical therapy; in the home, per diem | 1,861 | 1,840 | $677K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 5,043 | 4,998 | $642K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 5,226 | 4,989 | $638K |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 886 | 882 | $634K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 28,953 | 25,724 | $597K |
| 96361 | Intravenous infusion, hydration; each additional hour | 7,495 | 6,540 | $580K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 12,475 | 6,969 | $569K |
| 99442 | 9,886 | 9,434 | $568K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 16,615 | 15,923 | $533K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 7,064 | 5,624 | $529K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 32,811 | 32,602 | $527K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 15,963 | 15,573 | $475K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 699 | 691 | $428K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 877 | 872 | $417K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 9,836 | 9,055 | $402K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 783 | 778 | $398K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 3,014 | 2,809 | $392K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 4,296 | 4,251 | $380K |
| 99051 | 10,501 | 5,076 | $367K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 13,445 | 13,077 | $361K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2,253 | 2,212 | $350K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3,688 | 3,339 | $349K |
| 80048 | Basic metabolic panel (calcium, ionized) | 43,555 | 39,648 | $335K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2,037 | 2,001 | $334K |
| 80061 | Lipid panel | 32,551 | 32,020 | $330K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,246 | 2,193 | $329K |
| S9122 | Home health aide or certified nurse assistant, providing care in the home; per hour | 302 | 264 | $317K |
| 99443 | 4,299 | 4,047 | $314K | |
| 86480 | 5,040 | 4,887 | $307K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 18,541 | 14,698 | $303K |
| 85027 | 77,722 | 72,028 | $303K | |
| D0999 | Unspecified diagnostic procedure, by report | 1,873 | 1,811 | $299K |
| 82948 | 25,672 | 17,036 | $291K | |
| 80053 | Comprehensive metabolic panel | 23,749 | 21,080 | $270K |
| 90461 | 11,597 | 11,564 | $270K | |
| D9999 | Unspecified adjunctive procedure, by report | 1,818 | 1,734 | $250K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 12,792 | 12,743 | $242K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 32,806 | 32,230 | $239K |
| 83036 | Hemoglobin; glycosylated (A1C) | 33,486 | 32,658 | $231K |
| 84443 | Thyroid stimulating hormone (TSH) | 19,710 | 19,206 | $229K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1,368 | 1,362 | $218K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3,711 | 3,487 | $212K |
| H2010 | Comprehensive medication services, per 15 minutes | 2,831 | 2,591 | $212K |
| J0606 | Injection, etelcalcetide, 0.1 mg | 3,293 | 78 | $211K |
| 90791 | Psychiatric diagnostic evaluation | 1,094 | 972 | $208K |
| 99201 | 2,844 | 2,607 | $203K | |
| 97161 | 2,373 | 2,354 | $203K | |
| 86703 | 15,136 | 14,900 | $201K | |
| H0040 | Assertive community treatment program, per diem | 126 | 123 | $196K |
| 76770 | 1,431 | 1,415 | $194K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 8,700 | 8,599 | $193K |
| 80076 | 30,961 | 29,790 | $189K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 6,034 | 4,430 | $188K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2,911 | 2,814 | $187K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1,172 | 1,162 | $180K |
| 76641 | 1,568 | 1,364 | $175K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 9,991 | 9,941 | $168K |
| S9127 | Social work visit, in the home, per diem | 1,317 | 1,315 | $165K |
| 71046 | Radiologic examination, chest; 2 views | 9,633 | 9,349 | $162K |
| 99441 | 4,259 | 4,121 | $156K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 2,980 | 2,959 | $154K |
| 81422 | 234 | 232 | $154K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 13,564 | 12,526 | $153K |
| 90750 | 2,086 | 2,069 | $153K | |
| 0002A | 5,914 | 5,897 | $152K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 3,499 | 3,441 | $150K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1,719 | 1,704 | $148K |
| 0001A | 6,047 | 6,032 | $144K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 2,276 | 2,177 | $143K |
| J2794 | Injection, risperidone (risperdal consta), 0.5 mg | 554 | 339 | $141K |
| 97802 | 5,192 | 5,158 | $140K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 5,511 | 5,212 | $138K |
| 93970 | 692 | 683 | $136K | |
| 90677 | 1,225 | 1,221 | $135K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 800 | 768 | $135K |
| 90715 | 5,362 | 5,339 | $134K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6,632 | 6,340 | $123K |
| 87536 | 1,279 | 1,256 | $121K | |
| 90651 | 2,409 | 2,402 | $120K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 1,579 | 1,561 | $118K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 954 | 947 | $118K |
| 76801 | 930 | 908 | $116K | |
| 81161 | 544 | 541 | $115K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 9,132 | 8,491 | $110K |
| 71250 | 588 | 582 | $109K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 539 | 513 | $108K |
| 81329 | 854 | 833 | $107K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,570 | 1,545 | $107K |
| 81405 | 511 | 508 | $106K | |
| 90686 | 15,672 | 15,547 | $102K | |
| 88312 | 1,079 | 988 | $101K | |
| 99381 | 2,778 | 2,750 | $100K | |
| 86850 | 6,624 | 6,055 | $99K | |
| 0004A | 2,631 | 2,629 | $98K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 3,985 | 3,510 | $97K |
| 83655 | 8,856 | 8,741 | $96K | |
| 86803 | 8,764 | 8,652 | $95K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1,344 | 1,304 | $95K |
| 92250 | 2,390 | 2,336 | $94K | |
| 86780 | 9,259 | 8,913 | $94K | |
| 86003 | 2,146 | 1,942 | $93K | |
| 96040 | 1,150 | 1,116 | $90K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2,640 | 2,624 | $89K |
| 86769 | 2,947 | 2,805 | $82K | |
| 76536 | 744 | 742 | $78K | |
| 73630 | 3,617 | 3,213 | $77K | |
| 86360 | 1,547 | 1,504 | $76K | |
| 97010 | 10,066 | 4,931 | $75K | |
| 90734 | 1,576 | 1,571 | $75K | |
| 76830 | Ultrasound, transvaginal | 1,585 | 1,498 | $74K |
| 80358 | 6,504 | 3,061 | $73K | |
| 90746 | 1,273 | 1,264 | $70K | |
| 81361 | 548 | 545 | $67K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 1,884 | 1,724 | $66K |
| 70486 | 520 | 513 | $66K | |
| 92015 | Determination of refractive state | 2,789 | 2,788 | $66K |
| 87340 | 8,689 | 8,466 | $65K | |
| 71271 | 255 | 254 | $61K | |
| 86359 | 1,545 | 1,502 | $59K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 592 | 586 | $58K |
| 86901 | 6,735 | 6,070 | $58K | |
| 90697 | 1,147 | 1,146 | $58K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 5,626 | 5,084 | $56K |
| 84703 | 16,729 | 15,780 | $54K | |
| 11900 | 446 | 421 | $51K | |
| 81401 | 525 | 522 | $51K | |
| 73610 | 2,264 | 2,029 | $51K | |
| 81507 | 77 | 77 | $50K | |
| 81243 | 1,026 | 998 | $49K | |
| 94729 | 915 | 907 | $49K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1,939 | 1,256 | $48K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 661 | 295 | $48K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 7,504 | 7,462 | $48K |
| 99402 | 722 | 709 | $47K | |
| 86706 | 5,726 | 5,597 | $46K | |
| 90716 | 1,979 | 1,978 | $46K | |
| 94664 | 2,276 | 2,241 | $44K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1,555 | 1,554 | $44K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,888 | 3,713 | $44K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 10,389 | 9,737 | $43K |
| 86900 | 6,714 | 6,056 | $43K | |
| 90723 | 1,974 | 1,974 | $43K | |
| 92570 | 1,041 | 1,029 | $42K | |
| 87800 | 1,273 | 1,247 | $42K | |
| 0072A | 1,009 | 1,009 | $40K | |
| J1631 | Injection, haloperidol decanoate, per 50 mg | 2,376 | 2,270 | $40K |
| 81257 | 557 | 554 | $40K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 959 | 899 | $40K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2,440 | 2,325 | $40K |
| 96127 | 18,206 | 17,417 | $39K | |
| 76818 | 324 | 236 | $38K | |
| 73130 | 1,997 | 1,808 | $38K | |
| 71045 | Radiologic examination, chest; single view | 4,022 | 3,862 | $38K |
| 97165 | 434 | 433 | $38K | |
| 90732 | 404 | 396 | $38K | |
| 81001 | 19,963 | 18,526 | $37K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 94 | 93 | $37K |
| 90707 | 2,036 | 2,031 | $37K | |
| 92551 | 11,130 | 11,117 | $37K | |
| 86762 | 2,821 | 2,688 | $37K | |
| 0071A | 1,078 | 1,076 | $36K | |
| 88142 | 1,617 | 1,571 | $36K | |
| 73560 | 1,342 | 1,127 | $36K | |
| 97803 | 522 | 490 | $34K | |
| 99382 | 643 | 640 | $34K | |
| 0124A | 773 | 771 | $33K | |
| 17110 | 172 | 167 | $33K | |
| 82728 | 3,268 | 3,209 | $32K | |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 19 | 13 | $32K |
| 73030 | 1,565 | 1,454 | $32K | |
| 82805 | 4,051 | 3,746 | $32K | |
| 73564 | 1,167 | 1,105 | $32K | |
| 72100 | 1,069 | 1,059 | $32K | |
| 86765 | 2,672 | 2,550 | $31K | |
| 69210 | 185 | 179 | $31K | |
| 80361 | 1,622 | 964 | $31K | |
| 90680 | 1,190 | 1,188 | $31K | |
| 84146 | 1,598 | 1,527 | $30K | |
| 90480 | 845 | 844 | $29K | |
| 92557 | 772 | 768 | $29K | |
| 87522 | Neg quan hep c or qual rna | 749 | 734 | $29K |
| 86787 | 2,650 | 2,535 | $28K | |
| 94010 | 667 | 664 | $28K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 133 | 130 | $28K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 307 | 282 | $27K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 925 | 914 | $27K |
| 84439 | 3,640 | 3,552 | $27K | |
| 82607 | 2,905 | 2,878 | $27K | |
| 92134 | 709 | 660 | $27K | |
| 83020 | 2,081 | 1,982 | $26K | |
| 87486 | 1,767 | 1,752 | $26K | |
| 82785 | 1,752 | 1,712 | $26K | |
| J2426 | Injection, paliperidone palmitate extended release (invega sustenna), 1 mg | 192 | 181 | $25K |
| 97116 | 1,152 | 928 | $25K | |
| 99384 | 391 | 390 | $24K | |
| 86735 | 2,268 | 2,185 | $24K | |
| 81255 | 538 | 535 | $23K | |
| 81400 | 525 | 522 | $23K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 4,252 | 4,217 | $23K |
| 83880 | 1,959 | 1,869 | $23K | |
| 86318 | 297 | 71 | $23K | |
| 83001 | 1,244 | 1,196 | $23K | |
| 92579 | 420 | 415 | $22K | |
| 97535 | Self-care/home management training, each 15 minutes | 739 | 713 | $22K |
| 90670 | 4,063 | 4,055 | $22K | |
| 81251 | 538 | 535 | $22K | |
| 81200 | 538 | 535 | $22K | |
| 82105 | 1,592 | 1,549 | $21K | |
| 84153 | 1,442 | 1,403 | $21K | |
| H1005 | Prenatal care, at-risk enhanced service package (includes h1001-h1004) | 353 | 325 | $21K |
| 87581 | 1,768 | 1,753 | $21K | |
| 90620 | 847 | 839 | $21K | |
| 86704 | 2,220 | 2,173 | $21K | |
| 73110 | 1,053 | 899 | $21K | |
| 91320 | 418 | 417 | $20K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 88 | 87 | $20K |
| 73502 | 721 | 679 | $20K | |
| 90698 | 1,124 | 1,122 | $20K | |
| 82951 | 1,795 | 1,687 | $19K | |
| H0049 | Alcohol and/or drug screening | 1,401 | 1,396 | $19K |
| 99385 | 350 | 342 | $19K | |
| 90633 | 2,072 | 2,070 | $19K | |
| 84702 | 2,983 | 2,673 | $19K | |
| 83002 | 1,028 | 986 | $19K | |
| 87535 | 534 | 515 | $19K | |
| 81260 | 538 | 535 | $18K | |
| 99383 | 284 | 283 | $18K | |
| 92567 | 788 | 780 | $18K | |
| J2704 | Injection, propofol, 10 mg | 5,784 | 5,441 | $17K |
| 10060 | 125 | 119 | $17K | |
| 85610 | 7,687 | 6,790 | $17K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 483 | 213 | $16K |
| 83550 | 2,957 | 2,908 | $16K | |
| 90656 | 1,307 | 1,307 | $16K | |
| 92083 | 339 | 312 | $16K | |
| 92133 | 489 | 467 | $16K | |
| 88304 | 470 | 456 | $15K | |
| 81025 | 3,741 | 3,573 | $15K | |
| 96161 | 3,824 | 3,718 | $14K | |
| 94726 | 183 | 182 | $14K | |
| Q3014 | Telehealth originating site facility fee | 2,376 | 2,106 | $13K |
| 83540 | 3,028 | 2,970 | $13K | |
| 41899 | Unlisted procedure, dentoalveolar structures | 14 | 14 | $13K |
| 83970 | 477 | 463 | $13K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 99 | 98 | $13K |
| 84484 | 8,556 | 6,929 | $13K | |
| 76870 | 176 | 172 | $12K | |
| 82043 | 2,987 | 2,922 | $12K | |
| 92558 | 653 | 634 | $12K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 6,741 | 5,194 | $12K |
| 93017 | 246 | 244 | $12K | |
| 87081 | 2,490 | 2,440 | $12K | |
| 83525 | 1,035 | 1,001 | $12K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 26 | 26 | $11K |
| 84402 | 478 | 466 | $11K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 238 | 205 | $11K |
| 96367 | 524 | 470 | $11K | |
| 85730 | 5,276 | 5,058 | $11K | |
| 90648 | 1,290 | 1,289 | $11K | |
| 86708 | 1,033 | 1,003 | $11K | |
| 84403 | 411 | 387 | $11K | |
| 83735 | 7,916 | 7,365 | $10K | |
| 90674 | 462 | 363 | $10K | |
| 90647 | 1,165 | 1,165 | $10K | |
| 83516 | 863 | 840 | $10K | |
| S9129 | Occupational therapy, in the home, per diem | 54 | 54 | $10K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 6,924 | 6,599 | $10K |
| 82977 | 2,599 | 2,553 | $10K | |
| 80047 | 1,164 | 1,123 | $10K | |
| D7140 | Extraction, erupted tooth or exposed root | 429 | 285 | $9K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 27 | 27 | $9K |
| 87186 | 1,790 | 1,637 | $9K | |
| 77080 | 294 | 285 | $9K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 6,090 | 5,534 | $9K |
| 87338 | 852 | 839 | $9K | |
| 88141 | 459 | 452 | $9K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 4,584 | 4,414 | $9K |
| 80320 | 3,448 | 3,152 | $9K | |
| 94060 | 88 | 87 | $9K | |
| 82746 | 977 | 966 | $9K | |
| 12001 | 42 | 42 | $8K | |
| 0081A | 181 | 181 | $8K | |
| 86038 | 844 | 823 | $8K | |
| 82274 | 690 | 685 | $8K | |
| 82310 | 220 | 16 | $8K | |
| J0515 | Injection, benztropine mesylate, per 1 mg | 394 | 363 | $8K |
| 0154A | 184 | 184 | $8K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 2,651 | 2,574 | $8K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,275 | 1,120 | $7K |
| 82652 | 228 | 225 | $7K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,944 | 1,859 | $7K |
| 90696 | 534 | 534 | $7K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 53 | 25 | $7K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 1,121 | 1,103 | $7K |
| 99401 | 275 | 265 | $7K | |
| 36593 | 13 | 12 | $7K | |
| 90700 | 526 | 525 | $6K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 109 | 81 | $6K |
| 73590 | 468 | 411 | $6K | |
| 88300 | 540 | 523 | $6K | |
| 83690 | 6,164 | 5,886 | $6K | |
| 29125 | 41 | 38 | $6K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 419 | 413 | $6K |
| 97162 | 54 | 54 | $5K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 1,462 | 1,428 | $5K |
| 82784 | 510 | 402 | $5K | |
| 86140 | 1,657 | 1,621 | $5K | |
| D0150 | Comprehensive oral evaluation - new or established patient | 639 | 577 | $5K |
| J7030 | Infusion, normal saline solution , 1000 cc | 7,360 | 6,857 | $5K |
| 80348 | 340 | 294 | $5K | |
| 95812 | 12 | 12 | $5K | |
| 76000 | 73 | 71 | $5K | |
| 82248 | 1,252 | 1,053 | $5K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 1,093 | 1,078 | $5K |
| 99397 | 202 | 185 | $5K | |
| 31575 | 14 | 13 | $5K | |
| 73565 | 128 | 128 | $5K | |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | 144 | 139 | $5K |
| 82570 | 1,262 | 1,125 | $5K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 52 | 49 | $5K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 5,562 | 5,238 | $4K |
| 0082A | 107 | 107 | $4K | |
| 82550 | 3,313 | 3,095 | $4K | |
| 85651 | 1,682 | 1,647 | $4K | |
| D0274 | Bitewings - four radiographic images | 743 | 733 | $4K |
| 83718 | 519 | 519 | $4K | |
| 86376 | 293 | 282 | $4K | |
| 0074A | 98 | 98 | $4K | |
| D1110 | Prophylaxis - adult | 320 | 320 | $4K |
| 90681 | 1,237 | 1,237 | $4K | |
| D0220 | Intraoral - periapical first radiographic image | 1,297 | 1,289 | $4K |
| 99409 | 291 | 290 | $4K | |
| 74178 | 12 | 12 | $4K | |
| 73562 | 280 | 254 | $4K | |
| 92550 | 117 | 117 | $4K | |
| 76813 | 30 | 29 | $3K | |
| 82670 | 121 | 119 | $3K | |
| 84156 | 1,154 | 1,056 | $3K | |
| D0330 | Panoramic radiographic image | 318 | 300 | $3K |
| S9470 | Nutritional counseling, dietitian visit | 25 | 25 | $3K |
| 99152 | 238 | 236 | $3K | |
| 93308 | 46 | 36 | $3K | |
| 99386 | 41 | 41 | $3K | |
| 73140 | 137 | 134 | $3K | |
| 92587 | 126 | 126 | $3K | |
| 96376 | 1,342 | 1,207 | $3K | |
| 82677 | 115 | 105 | $3K | |
| 83527 | 191 | 180 | $3K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 4,679 | 4,530 | $3K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 4,118 | 3,860 | $3K |
| 90846 | Family psychotherapy without the patient present, 50 minutes | 16 | 16 | $3K |
| 73090 | 194 | 172 | $3K | |
| 85045 | 879 | 832 | $2K | |
| 92202 | 108 | 108 | $2K | |
| 82465 | 573 | 573 | $2K | |
| H0038 | Self-help/peer services, per 15 minutes | 52 | 50 | $2K |
| 84100 | 1,228 | 1,120 | $2K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 70 | 57 | $2K |
| J0401 | Injection, aripiprazole (abilify maintena), 1 mg | 13 | 12 | $2K |
| 90662 | 251 | 251 | $2K | |
| 82803 | 727 | 659 | $2K | |
| 87631 | 151 | 150 | $2K | |
| 82247 | 556 | 400 | $2K | |
| 90744 | 265 | 264 | $2K | |
| 95117 | 181 | 65 | $2K | |
| D0140 | Limited oral evaluation - problem focused | 308 | 300 | $2K |
| 96380 | 228 | 228 | $2K | |
| 70498 | 15 | 13 | $2K | |
| 99241 | 14 | 14 | $2K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 67 | 51 | $2K |
| 86592 | 749 | 689 | $2K | |
| 98960 | 82 | 80 | $2K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 33 | 31 | $2K |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 33 | 26 | $2K |
| 76857 | 53 | 52 | $2K | |
| 94760 | 783 | 763 | $2K | |
| 83605 | 1,464 | 1,315 | $2K | |
| 80354 | 4,152 | 2,354 | $2K | |
| D1206 | Topical application of fluoride varnish | 578 | 578 | $2K |
| S3645 | Hiv-1 antibody testing of oral mucosal transudate | 30 | 28 | $2K |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 177 | 149 | $2K |
| 88160 | 80 | 80 | $2K | |
| 87521 | Neg quan hep c or qual rna | 70 | 66 | $2K |
| D0120 | Periodic oral evaluation - established patient | 339 | 336 | $2K |
| 84704 | 115 | 105 | $2K | |
| 81003 | 824 | 796 | $2K | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | 41 | 40 | $2K |
| 73070 | 106 | 97 | $2K | |
| 86336 | 115 | 105 | $2K | |
| H0050 | Alcohol and/or drug services, brief intervention, per 15 minutes | 26 | 26 | $2K |
| 85379 | 966 | 945 | $2K | |
| 73521 | 102 | 101 | $2K | |
| 80165 | 196 | 186 | $2K | |
| 87177 | 144 | 141 | $2K | |
| 86696 | 87 | 81 | $1K | |
| 93923 | 12 | 12 | $1K | |
| 90653 | 110 | 110 | $1K | |
| 99188 | 189 | 187 | $1K | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 36 | 36 | $1K |
| 90694 | 108 | 108 | $1K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 16 | 16 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,871 | 1,609 | $1K |
| 86255 | 99 | 88 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,442 | 2,293 | $1K |
| 82150 | 320 | 310 | $1K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 925 | 628 | $1K |
| 80346 | 126 | 82 | $1K | |
| 0012A | 59 | 59 | $1K | |
| 77072 | 41 | 41 | $1K | |
| 0083A | 25 | 25 | $1K | |
| 86580 | 1,219 | 1,208 | $1K | |
| 59025 | Fetal non-stress test | 12 | 12 | $1K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 59 | 58 | $1K |
| 99493 | 32 | 28 | $1K | |
| D0230 | Intraoral - periapical each additional radiographic image | 411 | 411 | $1K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3,631 | 3,580 | $1K |
| 87517 | 24 | 24 | $1K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1,084 | 1,073 | $868.80 |
| 83519 | 51 | 51 | $864.16 | |
| 86695 | 66 | 62 | $845.47 | |
| 0011A | 59 | 55 | $814.46 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 1,242 | 1,063 | $810.49 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 531 | 472 | $803.18 |
| 93325 | 34 | 33 | $798.37 | |
| 86800 | 52 | 50 | $788.88 | |
| 99173 | 5,381 | 5,378 | $783.74 | |
| 92227 | 30 | 30 | $758.45 | |
| 84305 | 41 | 41 | $757.94 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 203 | 199 | $736.80 |
| 87070 | 343 | 337 | $735.77 | |
| 86430 | 152 | 151 | $733.33 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 1,281 | 1,133 | $731.14 |
| 82010 | 580 | 524 | $698.83 | |
| 99153 | Mod sedat endo service >5yrs | 79 | 79 | $683.17 |
| 90678 | 77 | 77 | $676.79 | |
| 83615 | 188 | 186 | $653.23 | |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | 14 | 14 | $640.57 |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 83 | 65 | $619.50 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 69 | 55 | $598.10 |
| 91318 | 31 | 31 | $595.20 | |
| 91319 | 105 | 105 | $585.20 | |
| 15853 | 13 | 13 | $583.28 | |
| 93971 | 14 | 13 | $571.89 | |
| 84154 | 31 | 30 | $542.07 | |
| 82962 | 736 | 700 | $519.89 | |
| 87040 | 276 | 239 | $511.51 | |
| 88271 | 19 | 19 | $498.91 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 12 | 12 | $484.86 |
| 71101 | 27 | 24 | $473.34 | |
| 74018 | 29 | 28 | $459.76 | |
| 86705 | 45 | 44 | $456.32 | |
| 83010 | 44 | 43 | $454.63 | |
| J1815 | Injection, insulin, per 5 units | 678 | 443 | $440.83 |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 29 | 26 | $430.11 |
| J7050 | Infusion, normal saline solution, 250 cc | 772 | 572 | $415.66 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 239 | 238 | $392.02 |
| J1630 | Injection, haloperidol, up to 5 mg | 1,180 | 1,075 | $385.10 |
| 84481 | 25 | 25 | $384.36 | |
| 86709 | 44 | 43 | $376.85 | |
| 99407 | 12 | 12 | $375.00 | |
| 85018 | 157 | 157 | $369.95 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 12 | 12 | $344.16 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 4,053 | 3,442 | $332.64 |
| D0210 | Intraoral - complete series of radiographic images | 97 | 97 | $332.14 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 61 | 60 | $330.72 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,232 | 1,179 | $329.60 |
| 87590 | 652 | 649 | $322.78 | |
| D9310 | 15 | 15 | $312.00 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 450 | 412 | $298.91 |
| 3074F | 33,791 | 27,635 | $290.02 | |
| 82533 | 14 | 14 | $289.54 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 214 | 162 | $284.75 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 2,240 | 2,015 | $266.15 |
| 0073A | 13 | 13 | $264.54 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 880 | 741 | $264.13 |
| 90381 | 33 | 33 | $252.22 | |
| J9035 | Injection, bevacizumab, 10 mg | 24 | 24 | $242.93 |
| 85014 | 677 | 664 | $234.73 | |
| 96368 | 13 | 13 | $231.27 | |
| 85660 | 48 | 47 | $228.05 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 3,094 | 2,619 | $219.28 |
| 82952 | 52 | 51 | $212.35 | |
| 83883 | 15 | 13 | $211.36 | |
| 99406 | 73 | 72 | $211.06 | |
| 90714 | 54 | 54 | $208.79 | |
| 3078F | 38,067 | 30,794 | $195.83 | |
| D9430 | 32 | 30 | $193.60 | |
| J2060 | Injection, lorazepam, 2 mg | 1,141 | 1,038 | $186.12 |
| D1120 | Prophylaxis - child | 48 | 48 | $175.00 |
| 73080 | 29 | 29 | $167.78 | |
| 3079F | 7,907 | 7,026 | $164.46 | |
| J2680 | Injection, fluphenazine decanoate, up to 25 mg | 29 | 24 | $156.05 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 132 | 129 | $155.55 |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 75 | 61 | $155.00 |
| J7510 | Prednisolone oral, per 5 mg | 338 | 324 | $150.33 |
| 86593 | 52 | 51 | $129.31 | |
| 87077 | 258 | 257 | $128.41 | |
| 81000 | 662 | 654 | $126.53 | |
| 90474 | 12 | 12 | $125.57 | |
| 86225 | 12 | 12 | $122.75 | |
| 73060 | 12 | 12 | $114.80 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 51 | 51 | $106.94 |
| 82390 | 12 | 12 | $104.31 | |
| D0191 | 162 | 161 | $97.99 | |
| 88399 | 150 | 147 | $89.93 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 219 | 184 | $82.87 |
| G0008 | Administration of influenza virus vaccine | 259 | 259 | $75.30 |
| 90688 | 13 | 13 | $73.18 | |
| 96160 | 18 | 13 | $54.48 | |
| 82553 | 13 | 12 | $45.44 | |
| 84550 | 13 | 13 | $42.48 | |
| 93321 | 17 | 16 | $37.16 | |
| 87490 | 649 | 646 | $35.61 | |
| 81002 | 29 | 27 | $34.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 52 | 45 | $33.09 |
| 84155 | 13 | 13 | $32.98 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 13 | 13 | $29.67 |
| 90611 | 37 | 36 | $26.54 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 16 | 12 | $15.90 |
| D0272 | Bitewings - two radiographic images | 12 | 12 | $7.50 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 14 | 14 | $0.59 |
| 3077F | 5,578 | 4,670 | $0.17 | |
| 1159F | 6,643 | 4,768 | $0.00 | |
| 48510 | 149 | 149 | $0.00 | |
| 1160F | 4,381 | 3,465 | $0.00 | |
| 90685 | 1,162 | 1,162 | $0.00 | |
| 99080 | 1,453 | 239 | $0.00 | |
| 0502F | 105 | 79 | $0.00 | |
| 3016F | 580 | 580 | $0.00 | |
| 99499 | 4,163 | 2,914 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 52 | 50 | $0.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 33 | 33 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 99 | 97 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 16 | 16 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 112 | 110 | $0.00 |
| 3075F | 9,612 | 8,566 | $0.00 | |
| 4293F | 635 | 635 | $0.00 | |
| 1220F | 928 | 928 | $0.00 | |
| G0436 | Smoking and tobacco cessation counseling visit for the asymptomatic patient; intermediate, greater than 3 minutes, up to 10 minutes | 580 | 580 | $0.00 |
| 3080F | 2,200 | 1,880 | $0.00 | |
| 99429 | 180 | 133 | $0.00 | |
| 1126F | 119 | 116 | $0.00 | |
| 3008F | 264 | 258 | $0.00 | |
| 80050 | General health panel | 14 | 14 | $0.00 |
| 88720 | 14 | 14 | $0.00 | |
| 3044F | 346 | 343 | $0.00 | |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 36 | 35 | $0.00 |